rs11209050

Variant names:

• chr1-67326053-A-C
• rs11209050
• NM_001374259.2:c.365-682A>C

Your query was ambiguous. Multiple possible variants found:

• chr1-67326053-A-C
• chr1-67326053-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001374259.2(IL12RB2):​c.365-682A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.685 in 152,098 control chromosomes in the GnomAD database, including 38,467 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.68 (38467 hom., cov: 32)
• Consequence: IL12RB2 NM_001374259.2 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.382
• Publications: 13 publications found

Genes affected

IL12RB2 (HGNC:5972): (interleukin 12 receptor subunit beta 2) The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.98).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.806 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
IL12RB2	NM_001374259.2	c.365-682A>C		intron_variant	Intron 4 of 16	ENST00000674203.2	NP_001361188.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
IL12RB2	ENST00000674203.2	c.365-682A>C		intron_variant	Intron 4 of 16		NM_001374259.2	ENSP00000501329.1

Frequencies

GnomAD3 genomes AF: 0.685 AC: 104137 AN: 151980 Hom.: 38466 Cov.: 32

Gnomad AFR AF: 0.384

Gnomad AMI AF: 0.868

Gnomad AMR AF: 0.722

Gnomad ASJ AF: 0.690

Gnomad EAS AF: 0.727

Gnomad SAS AF: 0.806

Gnomad FIN AF: 0.900

Gnomad MID AF: 0.684

Gnomad NFE AF: 0.812

Gnomad OTH AF: 0.694

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.685 AC: 104164 AN: 152098 Hom.: 38467 Cov.: 32 AF XY: 0.692 AC XY: 51426 AN XY: 74352

African (AFR) AF: 0.383 AC: 15890 AN: 41458

American (AMR) AF: 0.723 AC: 11041 AN: 15280

Ashkenazi Jewish (ASJ) AF: 0.690 AC: 2397 AN: 3472

East Asian (EAS) AF: 0.727 AC: 3767 AN: 5180

South Asian (SAS) AF: 0.805 AC: 3879 AN: 4818

European-Finnish (FIN) AF: 0.900 AC: 9508 AN: 10568

Middle Eastern (MID) AF: 0.697 AC: 205 AN: 294

European-Non Finnish (NFE) AF: 0.812 AC: 55228 AN: 68002

Other (OTH) AF: 0.689 AC: 1457 AN: 2114

Alfa AF: 0.758 Hom.: 56933

Bravo AF: 0.655

Asia WGS AF: 0.693 AC: 2410 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.98
CADD	Benign	1.5
DANN	Benign	0.32
PhyloP100		-0.38
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs11209050; hg19: chr1-67791736; COSMIC: COSV52021498; COSMIC: COSV52021498;